HealthTree Reports Live from Rio the Latest in Myeloma Research!
The HealthTree team is back from Rio de Janeiro, Brazil, where we attended the 21st annual meeting of the International Myeloma Society (IMS) last week! This leading conference brought together myeloma experts from around the globe to discuss cutting-edge research, treatments, and the unmet needs of the myeloma community.
The educational sessions were packed with valuable information, covering all stages of myeloma and providing an overview of the most recent data. We were busy behind the scenes conducting interviews with world-renowned myeloma specialists to bring you exclusive insights into the latest advancements in the field.
To kick things off, we're thrilled to share a highlight video presented by Dr. Angela Dispenzieri, summarizing key takeaways from the conference.
Stay tuned! In the coming days, we'll be uploading all of our exclusive expert interviews and in-depth articles to HealthTree University, providing you with a comprehensive overview of the latest developments in myeloma research and treatment. You can access all the videos here:
IMS Conference Updates - Expert Interviews
As always, you can find the latest on our conference coverage by visiting our Myeloma News site and subscribing to our weekly newsletter.
The progress being made makes us hopeful about the future of myeloma treatment for all patients. It was incredibly inspiring to connect with the myeloma community, colleagues, and partners at IMS in Rio.
We remain dedicated to providing you with the most current and relevant information to empower you to have an active role in your care and treatment decisions because educated patients live better and live longer.
Keep up-to-date with HealthTree as we continue to release interviews, articles, and key takeaways from this informative conference.
The HealthTree team is back from Rio de Janeiro, Brazil, where we attended the 21st annual meeting of the International Myeloma Society (IMS) last week! This leading conference brought together myeloma experts from around the globe to discuss cutting-edge research, treatments, and the unmet needs of the myeloma community.
The educational sessions were packed with valuable information, covering all stages of myeloma and providing an overview of the most recent data. We were busy behind the scenes conducting interviews with world-renowned myeloma specialists to bring you exclusive insights into the latest advancements in the field.
To kick things off, we're thrilled to share a highlight video presented by Dr. Angela Dispenzieri, summarizing key takeaways from the conference.
Stay tuned! In the coming days, we'll be uploading all of our exclusive expert interviews and in-depth articles to HealthTree University, providing you with a comprehensive overview of the latest developments in myeloma research and treatment. You can access all the videos here:
IMS Conference Updates - Expert Interviews
As always, you can find the latest on our conference coverage by visiting our Myeloma News site and subscribing to our weekly newsletter.
The progress being made makes us hopeful about the future of myeloma treatment for all patients. It was incredibly inspiring to connect with the myeloma community, colleagues, and partners at IMS in Rio.
We remain dedicated to providing you with the most current and relevant information to empower you to have an active role in your care and treatment decisions because educated patients live better and live longer.
Keep up-to-date with HealthTree as we continue to release interviews, articles, and key takeaways from this informative conference.
about the author
Jennifer Ahlstrom
Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can contribute to cures by joining HealthTree Cure Hub and joining clinical research. Founder and CEO of HealthTree Foundation.
More on Conferences
Trending Articles
Upcoming Events
Get the latest thought leadership on your Multiple Myeloma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.